Barak S, Goltseker K (2021) Targeting the reconsolidation of licit drug memories to prevent relapse: focus on alcohol and nicotine. Int J Mol Sci 22(8):4090

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker HC, Lopez MF (2004) Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol Clin Exp Res 28(12):1829–1838

Article  CAS  PubMed  Google Scholar 

Bernardi RE, Lattal KM, Berger SP (2007) Anisomycin disrupts a contextual memory following reactivation in a cocaine-induced locomotor activity paradigm. Behav Neurosci 121(1):156–163

Article  CAS  PubMed  Google Scholar 

Bogenschutz MP (2013) Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Curr Drug Abuse Rev 6(1):17–29

Article  CAS  PubMed  Google Scholar 

Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (2015) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29(3):289–299

Article  CAS  PubMed  Google Scholar 

Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O’Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L (2022) Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 79(10):953–962

Article  PubMed  PubMed Central  Google Scholar 

Borruto AM, Stopponi S, Li H, Weiss F, Roberto M, Ciccocioppo R (2021) Genetically selected alcohol-preferring msP rats to study alcohol use disorder: anything lost in translation? Neuropharmacology 15(186):108446

Article  Google Scholar 

Cameron LP, Benson CJ, Dunlap LE, Olson DE (2018) Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression. ACS Chem Neurosci 9(7):1582–1590

Article  CAS  PubMed  Google Scholar 

Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX (2005) Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. J Cogn Neurosci 17(10):1497–1508

Article  PubMed  Google Scholar 

Ciccocioppo R, Economidou D, Cippitelli A, Cucculelli M, Ubaldi M, Soverchia L, Lourdusamy A, Massi M (2006) Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol 11(3–4):339–355

Article  PubMed  PubMed Central  Google Scholar 

Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L (1997) Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol 106(2):243–250

Article  CAS  PubMed  Google Scholar 

Das RK, Gale G, Walsh K, et al. (2019) Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories [published correction appears in Nat Commun. 2020 11;11(1):3065]. Nat Commun 10(1):5187

Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R (2022) Increased global integration in the brain after psilocybin therapy for depression. Nat Med 28(4):844–851

Article  CAS  PubMed  Google Scholar 

De Veen BT, Schellekens AF, Verheij MM, Homberg JR (2017) Psilocybin for treating substance use disorders? Expert Rev Neurother 17(2):203–212

Article  PubMed  Google Scholar 

Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS (2021) Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry 11(1):574

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dudai Y (2004) The neurobiology of consolidations, or, how stable is the engram? Annu Rev Psychol 55:51–86

Article  PubMed  Google Scholar 

Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M, Crabbe JC, Roberts AJ (2007) Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12–41). Alcohol Clin Exp Res 31(6):939–949

Article  CAS  PubMed  Google Scholar 

Fuhrmann D, Knoll LJ, Blakemore SJ (2015) Adolescence as a sensitive period of brain development. Trends Cogn Sci 19(10):558–566

Article  PubMed  Google Scholar 

Gallimore AR (2015) Restructuring consciousness -the psychedelic state in light of integrated information theory. Front Hum Neurosci 12(9):346

Google Scholar 

Golden CT, Chadderton P (2022) Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents. Sci Rep 12(1):12702

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, Huang B, Jung J, Zhang H, Fan A, Hasin DS (2017) Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the national epidemiologic survey on alcohol and related conditions. JAMA Psychiat 74(9):911–923

Article  Google Scholar 

Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68(1):71–78

Article  CAS  PubMed  Google Scholar 

Healy CJ (2021) The acute effects of classic psychedelics on memory in humans. Psychopharmacology 238(3):639–653

Article  CAS  PubMed  Google Scholar 

Hellemans KG, Everitt BJ, Lee JL (2006) Disrupting reconsolidation of conditioned withdrawal memories in the basolateral amygdala reduces suppression of heroin seeking in rats. J Neurosci 26(49):12694–9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565–598

Article  CAS  PubMed  Google Scholar 

Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA (2018) Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology 142:72–82

Article  CAS  PubMed  Google Scholar 

Jefsen O, Højgaard K, Christiansen SL, Elfving B, Nutt DJ, Wegener G, Müller HK (2019) Psilocybin lacks antidepressant-like effect in the Flinders sensitive line rat. Acta Neuropsychiatr 31(4):213–219

Article  PubMed  Google Scholar 

Jefsen OH, Elfving B, Wegener G, Müller HK (2021) Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin. J Psychopharmacol 35(4):483–493

Article  CAS  PubMed  Google Scholar 

Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22(6):603–620

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol 28(11):983–992

Article  PubMed  PubMed Central  Google Scholar 

Kelley AE (2004) Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron. 44(1):161–79

Article  CAS  PubMed  Google Scholar 

Koob GF, Roberts AJ, Kieffer BL, Heyser CJ, Katner SN, Ciccocioppo R, Weiss F (2003) Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology. Recent Dev Alcohol 16:263–281

PubMed  Google Scholar 

Lapidus KA, Levitch CF, Perez AM et al (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76(12):970–976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JL, Di Ciano P, Thomas KL, Everitt BJ (2005) Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior. Neuron. 47(6):795–801

Article  CAS  PubMed  Google Scholar 

Lee JL, Milton AL, Everitt BJ (2006) Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J Neurosci. 26(22):5881–7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Litten RZ, Falk DE, Ryan ML, Fertig J, Leggio L (2018) Advances in pharmacotherapy development: human clinical studies. Handb Exp Pharmacol 248:579–613

Article  PubMed  Google Scholar 

Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Soltanzadeh Zarandi S, Sood A, Paddy MR, Duim WC, Dennis MY, McAllister AK, Ori-McKenney KM, Gray JA, Olson DE (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep. 23(11):3170–3182

Article  CAS  PubMed  PubMed Central  Google Scholar